CIK 0001439725 · Non-accelerated filer<br>Smaller reporting company
BIODESIX INC
Sign in to watch- Ticker
- BDSX
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203986492
- Phone
- 303-417-0500
- Business address
- 919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
- Open-market buys, last 90 days
- $1,001,990
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,001,990. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | SCHULER JACK W 10% owner | Purchase | +100,000 | $10.02 | $1.0M | 655,810 |
| 2026-09-30 | PATIENCE JOHN Director | Option exercise | +1,360 | 26,743 | ||
| 2026-09-30 | PATIENCE JOHN Director | Option exercise · Restricted Stock Units | −1,360 | 1,361 | ||
| 2026-08-12 | SCHULER JACK W 10% owner | Purchase | +15,000 | $24.47 | $367K | 555,810 |
| 2026-08-11 | SCHULER JACK W 10% owner | Purchase | +13,700 | $24.01 | $329K | 540,810 |
| 2026-08-10 | SCHULER JACK W 10% owner | Purchase | +13,900 | $24.25 | $337K | 527,110 |
| 2026-06-30 | PATIENCE JOHN Director | Option exercise | +1,361 | 25,383 | ||
| 2026-06-30 | PATIENCE JOHN Director | Option exercise · Restricted Stock Units | −1,361 | 2,721 | ||
| 2026-03-31 | PATIENCE JOHN Director | Option exercise | +1,361 | 24,022 | ||
| 2026-03-31 | PATIENCE JOHN Director | Option exercise · Restricted Stock Units | −1,361 | 4,082 | ||
| 2026-02-23 | Vazquez Chris Chief Accounting Officer | Sale | −211 | $12.78 | $3K | 1,586 |
| 2026-02-23 | Cowie Robin Harper CFO, Sec'y & Treasurer | Sale | −535 | $12.78 | $7K | 16,231 |
| 2026-02-23 | Hutton Scott President & CEO | Sale | −1,490 | $12.78 | $19K | 48,767 |
| 2026-02-23 | Pestano Gary Anthony Chief Development Officer | Sale | −556 | $12.78 | $7K | 10,359 |
| 2026-02-23 | O'Kane Kieran Chief Commercial Officer | Sale | −535 | $12.78 | $7K | 9,819 |
| 2026-02-20 | Vazquez Chris Chief Accounting Officer | Option exercise | +563 | 1,797 | ||
| 2026-02-20 | Vazquez Chris Chief Accounting Officer | Option exercise · Restricted Stock Units | −563 | 1,689 | ||
| 2026-02-20 | Cowie Robin Harper CFO, Sec'y & Treasurer | Option exercise | +1,469 | 16,766 | ||
| 2026-02-20 | Cowie Robin Harper CFO, Sec'y & Treasurer | Option exercise · Restricted Stock Units | −1,469 | 4,406 | ||
| 2026-02-20 | Hutton Scott President & CEO | Option exercise | +4,844 | 50,257 |
Page 1 of 6 · 115 trades